-
David William Gray, PhD
… to the selection of 10 clinical candidates across multiple disease areas and the recent partnering of a …
-
BioFIND
… protocols to ensure that tests and assessments conducted at multiple sites can be pooled. Data Characteristics Study …
-
Elevated in vitro kinase activity in PBMCs > of LRRK2 G2019S carriers: a novel ELISA-based method
May 18, 2020
… immunosorbent assay-based assays capable of detecting multiple aspects of leucine-rich repeat kinase 2 function at …
-
Characterization of the Contributions of Alpha-synuclein and Tau Aggregation in a Preclinical Model of Parkinson’s Disease Progression
… as a means to understand disease progression in PD. We will systematically characterize pathology progression patterns … is a driving factor in the development of dementia in PD, multiple or broad-spectrum therapies may be necessary to …
-
The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy
September 11, 2021
… compounds and identified A-443654, an inhibitor of the multiple functional kinase AKT, as a potent inhibitor of …
-
Pinky’s Passion Walk to the Future without Parkinson’s on 7/28
July 16, 2012
… coupled with their passion for the cause eventually led to multiple annual fundraisers for Parkinson’s research, …